Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Citi
Argus Health
Dow
Chinese Patent Office
Cantor Fitzgerald
Chubb
Farmers Insurance
Fuji

Generated: February 18, 2018

DrugPatentWatch Database Preview

Sunovion Resp Company Profile

« Back to Dashboard

What is the competitive landscape for SUNOVION RESP, and when can generic versions of SUNOVION RESP drugs launch?

SUNOVION RESP has one approved drug.

There are nine US patents protecting SUNOVION RESP drugs.

There are sixty-five patent family members on SUNOVION RESP drugs in thirteen countries.

Summary for Sunovion Resp
International Patents:65
US Patents:9
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Sunovion Resp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 7,458,372 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 7,931,212 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 6,962,151 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,604,018 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 7,316,067 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,789,270 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,168,556 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 8,511,581 ➤ Try a Free Trial Y ➤ Try a Free Trial
Sunovion Resp LONHALA MAGNAIR KIT glycopyrrolate SOLUTION;INHALATION 208437-001 Dec 5, 2017 RX Yes Yes 9,265,900 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Sunovion Resp Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Farmers Insurance
Mallinckrodt
US Department of Justice
Chubb
Dow
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot